Schizofrenia
Zapobieganie i profilaktyka

Schizofrenia jest poważnym zaburzeniem psychicznym, którego profilaktyka opiera się na wczesnej identyfikacji osób z grup ryzyka oraz interwencjach na różnych poziomach: uniwersalnym, selektywnym i wskazanym. Kluczowe jest rozpoznanie faz prodromalnych (EPRS, LPRS) za pomocą narzędzi takich jak CAARMS i SIPS, co umożliwia wdrożenie terapii poznawczo-behawioralnej, terapii rodzinnej oraz treningu umiejętności społecznych. Wczesna interwencja może zmniejszyć ryzyko progresji do pełnoobjawowej psychozy o ponad 50% w ciągu 12 miesięcy. Farmakoterapia profilaktyczna obejmuje ostrożne stosowanie atypowych leków przeciwpsychotycznych oraz suplementację kwasami omega-3 (700 mg EPA i 480 mg DHA dziennie przez 12 tygodni), co w badaniu Vienna omega-3 study obniżyło wskaźnik konwersji do psychozy z 40% do 9,8%. Istotne są także modyfikacje stylu życia, w tym unikanie substancji psychoaktywnych, zwłaszcza marihuany, oraz wsparcie społeczne i psychoedukacja rodzin.

Wprowadzenie do profilaktyki schizofrenii

Schizofrenia jest poważnym zaburzeniem psychicznym, które istotnie wpływa na jakość życia pacjentów i ich rodzin. W nowoczesnej medycynie coraz większą wagę przykłada się do działań prewencyjnych i profilaktycznych w zakresie chorób psychicznych. Chociaż nie istnieje pewny sposób na całkowite zapobieganie schizofrenii, badania wskazują na możliwości zmniejszenia ryzyka rozwoju choroby lub złagodzenia jej przebiegu poprzez wczesną interwencję i odpowiednią profilaktykę.12

Profilaktyka zaburzeń psychotycznych, w tym schizofrenii, może być realizowana na kilku poziomach. Wyróżnia się profilaktykę uniwersalną (skierowaną do ogółu populacji), selektywną (skupioną na grupach ryzyka) oraz wskazaną (ukierunkowaną na osoby z wczesnymi objawami prodromalnymi). Ta ostatnia odgrywa szczególną rolę w zapobieganiu rozwojowi pełnoobjawowej schizofrenii.13

Badania wskazują, że wczesna diagnoza i interwencja mogą znacząco poprawić długoterminowe wyniki leczenia oraz jakość życia pacjentów. Wykazano, że wczesne wykrywanie i interwencja u osób z ultra-wysokim ryzykiem rozwoju psychozy mogą zapobiec lub opóźnić pierwszy epizod psychotyczny, zmniejszając ryzyko rozwoju schizofrenii o ponad 50% po 12 miesiącach.45

Identyfikacja czynników ryzyka w profilaktyce schizofrenii

Zrozumienie czynników ryzyka jest kluczowe dla skutecznych działań profilaktycznych. Badania wskazują na złożoną interakcję czynników biologicznych, psychologicznych i społecznych w rozwoju schizofrenii, zgodnie z biopsychospołecznym modelem zaburzeń psychicznych.6

Czynniki ryzyka biologicznego

Wśród biologicznych czynników ryzyka wymienia się przede wszystkim:

  • Predyspozycje genetyczne – ryzyko jest wyższe u osób, których krewni (zwłaszcza pierwszego stopnia) chorują na schizofrenię7
  • Powikłania okołoporodowe i podczas ciąży – infekcje, stres, stany przedrzucawkowe8
  • Niedobory odżywcze podczas ciąży, szczególnie kwasu foliowego9
  • Molekularne zmiany występujące już przed klinicznym początkiem choroby10

Badania sugerują, że odpowiednia opieka prenatalna i okołoporodowa może zmniejszyć ryzyko rozwoju schizofrenii u potomstwa. Szczególną uwagę zwraca się na właściwe odżywianie podczas ciąży, w tym suplementację kwasem foliowym, który może mieć działanie neuroprotekcyjne.911

Czynników ryzyka środowiskowego

Do istotnych czynników środowiskowych należą:

  • Traumatyczne doświadczenia w dzieciństwie, w tym urazy mózgu i przemoc seksualna8
  • Nadużywanie substancji psychoaktywnych, szczególnie marihuany, kokainy i amfetamin1213
  • Izolacja społeczna i brak wsparcia społecznego14
  • Silny stres i traumatyczne przeżycia12
  • Życie w środowisku miejskim15

Jak wskazują badania, dzieci, które doświadczyły traumy przed 16 rokiem życia, mają trzykrotnie wyższe ryzyko rozwoju psychozy. W przypadku ciężkiej traumy ryzyko to może być nawet 50 razy wyższe.12

Strategie wczesnego wykrywania zagrożenia schizofrenią

Wczesne wykrywanie osób zagrożonych rozwojem schizofrenii jest kluczowym elementem skutecznej profilaktyki. Czas nieleczonej psychozy (DUP – Duration of Untreated Psychosis) istotnie wpływa na dalszy przebieg choroby, dlatego szybka identyfikacja osób z grup ryzyka jest niezwykle ważna.10

Identyfikacja objawów prodromalnych

W rozpoznawaniu stanów wysokiego ryzyka rozwoju psychozy (At-Risk Mental State, ARMS) wykorzystuje się wystandaryzowane narzędzia diagnostyczne, takie jak:

  • Comprehensive Assessment of At-Risk Mental States (CAARMS)16
  • Structured Interview for Prodromal Symptoms (SIPS)16

Badacze wyróżniają dwie fazy prodromalne: wczesną fazę prodromalną (EPRS – Early Initial Prodromal States) charakteryzującą się podstawowymi objawami oraz późną fazę prodromalną (LPRS – Late Initial Prodromal States) z objawami wysokiego ryzyka.117

W identyfikacji osób z grup ryzyka dąży się obecnie do wzbogacenia oceny opartej na objawach o biomarkery neurobiologiczne, co może zwiększyć dokładność przewidywania rozwoju schizofrenii.18

Centra wczesnej interwencji

Na całym świecie powstają centra wczesnego rozpoznawania zaburzeń psychotycznych, które prowadzą działania diagnostyczne i profilaktyczne. Przykładem są:

  • Prevention and Recovery Center for Early Psychosis (PARC) w Stanach Zjednoczonych19
  • Centra w ramach programu PIER (Portland Identification and Early Referral)20
  • Niemieckie centra wczesnego rozpoznawania21

Działania tych ośrodków koncentrują się na identyfikacji osób z grup ryzyka, edukacji, wsparciu oraz wdrażaniu odpowiednich interwencji profilaktycznych.1922

Interwencje profilaktyczne w schizofrenii

Strategie profilaktyczne w schizofrenii obejmują różnorodne interwencje, które można dostosować do specyficznych potrzeb osób z grup ryzyka oraz fazy prodromalnej.17

Interwencje psychoterapeutyczne

Wśród skutecznych interwencji psychoterapeutycznych wymienia się przede wszystkim:

  • Terapię poznawczo-behawioralną (CBT) – szczególnie zalecana w początkowych fazach prodromalnych, pomaga w radzeniu sobie ze stresem i redukuje ryzyko progresji do pełnoobjawowej psychozy123
  • Terapię rodzinną – warsztaty wielorodzinne i sesje psychoedukacyjne pomagające w łagodzeniu wzorców komunikacji i rozwiązywaniu konfliktów22
  • Trening umiejętności społecznych – wspierający rozwój kompetencji interpersonalnych i zapobiegający izolacji społecznej24
  • Terapię adherencyjną – zwiększającą przestrzeganie zaleceń terapeutycznych24

Niemieckie badania wykazały, że stosowanie interwencji psychologicznych obejmujących terapię poznawczo-behawioralną, trening umiejętności grupowych, usprawnianie funkcji poznawczych i psychoedukację wielorodzinną może opóźnić wystąpienie psychozy o co najmniej 2 lata.18

Interwencje farmakologiczne

W zakresie farmakoterapii profilaktycznej rozważa się:

  • Leki przeciwpsychotyczne w niskich dawkach – atypowe leki przeciwpsychotyczne są badane jako potencjalna interwencja w późnej fazie prodromalnej, jednak ich rutynowe stosowanie w okresie ARMS nie jest obecnie zalecane116
  • Suplementy kwasów omega-3 – badania sugerują, że mogą one zapobiegać progresji do psychozy i zapewniać długotrwałą poprawę objawową i funkcjonalną u osób z grup wysokiego ryzyka2526
  • Środki neuroprotekcyjne – badane są substancje mogące chronić mózg przed progresją zmian strukturalnych27
  • Modulatory glutaminergiczne – jako potencjalne interwencje wpływające na przekaźnictwo nerwowe27

Szczególnie obiecujące wydają się wyniki dotyczące suplementacji kwasami omega-3. Badanie Vienna omega-3 study wykazało, że 12-tygodniowa interwencja z zastosowaniem kwasów omega-3 (700 mg kwasu eikozapentaenowego i 480 mg kwasu dokozaheksaenowego dziennie) znacząco zmniejszyła ryzyko progresji do zaburzenia psychotycznego w porównaniu z placebo. Skumulowany wskaźnik konwersji do psychozy w dłuższej obserwacji wynosił 9,8% w grupie otrzymującej kwasy omega-3 i 40% w grupie placebo.2628

Modyfikacje stylu życia w profilaktyce schizofrenii

Istotną rolę w profilaktyce schizofrenii odgrywają także modyfikacje stylu życia, które mogą zmniejszyć ryzyko rozwoju choroby lub jej nawrotów.12

Unikanie substancji psychoaktywnych

Unikanie narkotyków i alkoholu jest kluczowym elementem profilaktyki schizofrenii, zwłaszcza u osób z grup ryzyka. Wczesne i długotrwałe używanie marihuany i innych narkotyków może zwiększać ryzyko rozwoju choroby.1213

Szczególnie istotne jest to u nastolatków, których mózgi wciąż się rozwijają. Wiele osób doświadcza przejściowej psychozy pod wpływem substancji psychoaktywnych, ale w niektórych przypadkach objawy te mogą się utrzymywać i prowadzić do rozwoju przewlekłych zaburzeń psychotycznych.14

Dla osób zmagających się jednocześnie z uzależnieniem i zaburzeniami psychicznymi, pomocne mogą być programy podwójnej diagnozy, skierowane na jednoczesne leczenie obu problemów.24

Wsparcie społeczne i redukcja stresu

Utrzymywanie silnych więzi społecznych i unikanie izolacji ma duże znaczenie profilaktyczne. Socjalizacja pomaga w utrzymaniu samooceny, obniżeniu poziomu stresu i zapobieganiu poczuciu osamotnienia.12

Badania sugerują, że jednym z najlepszych sposobów zapobiegania rozwojowi schizofrenii jest unikanie izolacji społecznej. W izolacji, czy to z wyboru, czy przypadku, ludzie mogą rozwijać niezdrowe nawyki myślowe i zniekształcone rozumienie otaczającego świata.14

Równie ważne jest rozwijanie umiejętności radzenia sobie ze stresem, ponieważ długotrwały stres i niepokój niekorzystnie wpływają na zdrowie psychiczne i mogą przyczyniać się do rozwoju lub zaostrzenia objawów psychotycznych.12

Zapobieganie nawrotom schizofrenii

Istotnym aspektem profilaktyki w schizofrenii jest zapobieganie nawrotom choroby u osób, u których już zdiagnozowano to zaburzenie.29

Przestrzeganie zaleceń farmakoterapeutycznych

Podstawowym elementem zapobiegania nawrotom jest regularne przyjmowanie leków przeciwpsychotycznych, nawet po ustąpieniu objawów. Leki przeciwpsychotyczne są przepisywane po pierwszym epizodzie psychotycznym, a następnie kontynuowane profilaktycznie w celu uniknięcia nawrotu.3029

Przerwanie farmakoterapii wiąże się z wysokim ryzykiem nawrotu w ciągu 1-2 lat. W przypadku trudności z przestrzeganiem zaleceń dotyczących codziennego przyjmowania leków, można rozważyć leki przeciwpsychotyczne w formie depot/długodziałających preparatów do iniekcji.31

U pacjentów z częstymi nawrotami, u których standardowe leki przeciwpsychotyczne nie kontrolują wystarczająco objawów, można zastosować klozapinę – lek przeciwpsychotyczny zatwierdzony przez FDA do leczenia opornej schizofrenii.3132

Kompleksowa opieka i planowanie wypisu

Jakość opieki szpitalnej i właściwe przejście do opieki ambulatoryjnej mają kluczowe znaczenie w zmniejszaniu ryzyka nawrotu. Okres bezpośrednio po wypisie ze szpitala jest krytycznym czasem, charakteryzującym się zwiększonym ryzykiem ponownej hospitalizacji, samobójstwa i przerwania ciągłości opieki.33

Skuteczne planowanie wypisu powinno obejmować co najmniej jedno zaplanowane spotkanie ze wszystkimi zainteresowanymi stronami przed wypisem oraz zaangażowanie rodziny jako podstawowe elementy. Planowanie wypisu może zwiększyć wiedzę pacjenta, zmniejszyć objawy kliniczne i ograniczyć częstotliwość hospitalizacji.34

W badaniach klinicznych z randomizacją model interwencji w czasie krytycznym (CTI) oraz asertywne leczenie środowiskowe (ACT) skutecznie zapobiegały bezdomności i ponownej hospitalizacji wśród pacjentów z ciężkimi chorobami psychicznymi po wypisie do społeczności.33

Rola rodziny w profilaktyce schizofrenii

Rodzina odgrywa kluczową rolę zarówno w profilaktyce, jak i leczeniu schizofrenii. Dynamika rodzinna może wpływać na nawroty, a czynniki takie jak niewystarczające wsparcie rodziny, wysoki poziom wyrażanych emocji, niewystarczająca wiedza o psychozie oraz wyzwania związane z opieką nad pacjentami ze schizofrenią mogą przyczyniać się do pogorszenia stanu pacjenta.35

Profilaktyka rodzinna obejmuje:

  • Psychoedukację rodzinną – zwiększającą wiedzę na temat choroby, jej objawów, leczenia i zapobiegania nawrotom24
  • Warsztaty umiejętności komunikacyjnych – pomagające w redukcji wysokiego poziomu wyrażanych emocji22
  • Grupy wsparcia dla rodzin – umożliwiające wymianę doświadczeń i wzajemne wsparcie36

Programy profilaktyczne McFarlane’a zakładają, że jeśli można wcześnie zidentyfikować młode osoby zagrożone schizofrenią, można zmienić niektóre z tych wzorców rodzinnych. Programy te angażują rodziny w dwumiesięczne wielorodzinne sesje terapii grupowej, gdzie uczestnicy podejmują praktyczne podejście do rozwiązywania sporów w domu i łagodzenia swoich reakcji na to, przez co przechodzi młoda osoba.22

Podejście zdrowia publicznego do profilaktyki schizofrenii

Skuteczna profilaktyka schizofrenii wymaga kompleksowego podejścia na poziomie zdrowia publicznego, uwzględniającego różne poziomy interwencji i grupy docelowe.17

Kampanie informacyjne i edukacyjne

Organizowane są kampanie zdrowia publicznego mające na celu edukację ogółu społeczeństwa na temat schizofrenii, specyficznych czynników ryzyka i wczesnych objawów choroby.13

Te działania edukacyjne mogą obejmować informacje na temat:

  • Znaczenia odpowiedniego odżywiania i unikania infekcji podczas ciąży37
  • Wczesnych objawów ostrzegawczych schizofrenii38
  • Szkodliwości używania substancji psychoaktywnych, szczególnie wśród młodzieży15

Niektórzy badacze proponują, jako pierwszy krok w kierunku uniwersalnej profilaktyki pierwotnej, duże kampanie edukujące młodych ludzi o szkodliwości regularnego używania marihuany o wysokiej potencji.15

Integracja systemów opieki zdrowotnej

Skuteczna profilaktyka wymaga dobrze skoordynowanej opieki i wsparcia podczas przejścia pacjenta ze szpitala do stałej opieki środowiskowej.33

System opieki zdrowotnej powinien zapewniać dostępność zasobów ludzkich dla zdrowia na wszystkich poziomach placówek zdrowotnych, a praca zespołów multidyscyplinarnych pomoże w zapewnieniu udanego przejścia.39

Integracja opieki pierwotnej i zdrowia psychicznego jest jedną z kluczowych praktyk, które mogą poprawić wyniki leczenia osób ze schizofrenią.36

Przyszłe kierunki w profilaktyce schizofrenii

Badania nad profilaktyką schizofrenii stale się rozwijają, otwierając nowe możliwości w zakresie wczesnego wykrywania i interwencji. Przyszłe kierunki badań i praktyki klinicznej obejmują:

Badania nad biomarkerami

Naukowcy poszukują bardziej konkretnych markerów ryzyka w mózgu, krwi i ślinie, aby lepiej identyfikować osoby zagrożone. Te biomarkery mogą pomóc w opracowaniu bardziej precyzyjnych strategii profilaktycznych.11

Badanie North American Prodrome Longitudinal Study bada, czy włączenie pomiarów biologicznych do algorytmów prognozowania może zapewnić dokładniejszą identyfikację młodych ludzi, którzy są najbardziej zagrożeni rozwojem zaburzenia psychotycznego. Celem tego badania jest ustalenie obiektywnych kryteriów, które można wykorzystać do opracowania podejść profilaktycznych.18

Technologie cyfrowe w profilaktyce

Technologie cyfrowe mogą pomóc w identyfikacji wczesnych oznak nawrotu. Monitorowanie za pomocą aplikacji mobilnych i innych narzędzi cyfrowych może umożliwić wczesną interwencję, zanim nawrót stanie się pełnoobjawowy i będzie wymagał znaczącej zmiany w leczeniu lub hospitalizacji.4041

Rozwiązania z zakresu zdrowia cyfrowego są również uwzględniane w zaleceniach dotyczących kompleksowych ścieżek opieki w schizofrenii.42

Podsumowanie

Profilaktyka schizofrenii jest złożonym zagadnieniem, wymagającym kompleksowego podejścia uwzględniającego czynniki biologiczne, psychologiczne i społeczne. Chociaż całkowite zapobieganie schizofrenii pozostaje wyzwaniem, istnieją obiecujące strategie, które mogą zmniejszyć ryzyko rozwoju choroby lub złagodzić jej przebieg.52

Kluczowe elementy skutecznej profilaktyki schizofrenii obejmują:

  • Wczesną identyfikację osób z grup ryzyka10
  • Interwencje psychoterapeutyczne, w tym terapię poznawczo-behawioralną23
  • Ostrożne stosowanie farmakoterapii w wybranych przypadkach1
  • Suplementację kwasami omega-3 u osób z wysokim ryzykiem28
  • Modyfikacje stylu życia, w tym unikanie substancji psychoaktywnych12
  • Wsparcie społeczne i rodzinne35
  • Regularne przyjmowanie leków w celu zapobiegania nawrotom30

Badania nad profilaktyką schizofrenii stale się rozwijają, a wyniki sugerują, że dzięki wczesnej interwencji i kompleksowej opiece możliwe jest poprawienie długoterminowych wyników leczenia i jakości życia osób zagrożonych tym poważnym zaburzeniem psychicznym.43

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3190243/
    In modern medicine, vigorous efforts are being made in the prediction and prevention of diseases. Mental disorders are suitable candidates for the application of this program. […] Research findings suggest a differential strategy of indicated prevention with cognitive behavioral therapy in early initial prodromal states and low dosage atypical antipsychotics in late initial prodromal states. The most important future tasks are the improvement of the predictive power by risk enrichment and stratification, as well as the confirmation of the existing and the development of new prevention strategies, with a stronger focus on the etiology of the disorder. […] Universal or selective prevention measures target healthy population groups or clinically still healthy risk carriers, respectively. Indicated prevention, instead, targets individuals with basic symptoms and UHR symptoms.
  • #2 Schizophrenia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443
    There’s no sure way to prevent schizophrenia. But staying with your treatment plan can help stop symptoms from returning or getting worse. Researchers hope that learning more about risk factors for schizophrenia may lead to earlier diagnosis and treatment. […] Proper treatment of schizophrenia can reduce the risk of suicide.
  • #3 Preventing Schizophrenia
    http://www.health.am/psy/more/preventing-schizophrenia/
    Prevention of an illness can take two forms: primary and secondary prevention. The goal of primary prevention is to prevent new cases of a disorder from ever developing. One way we can do this with schizophrenia is improving prenatal and obstetric care. Pregnancy and birth complications have been linked to schizophrenia. Clinicians and researchers speculate that by improving health and nutrition in pregnant women, we may prevent the development of schizophrenia in their offspring. […] The goal of secondary prevention is to identify those who are most at risk of developing schizophrenia and treat them early. […] The most important prevention challenge is to reduce the number of cases of schizophrenia in the population. In the absence of precise knowledge of etiopathophysiologic pathways to schizophrenia, primary prevention is based on risk factors.
  • #4 Schizophrenia Prevention: Risk Factors, Research, and Interventions
    https://psychcentral.com/schizophrenia/schizophrenia-prevention
    There is no sure way to prevent schizophrenia but there are ways to prevent or reduce symptoms, such as taking medication, avoiding substance use, and receiving therapy. […] Many people can prevent or reduce the severity of psychotic episodes by engaging with schizophrenia treatment. Early diagnosis and treatment can improve your long-term outcomes and quality of life. […] More research is needed, but some studies suggest that early interventions may help to prevent or reduce the symptoms or complications associated with schizophrenia. […] The authors concluded that, in people with an ultra-high risk of developing psychosis, early detection and intervention may prevent or delay the first episode of psychosis. The interventions reduced the risk of schizophrenia by over 50% after 12 months.
  • #5 Schizophrenia Prevention: Risk Factors, Research, and Interventions
    https://psychcentral.com/schizophrenia/schizophrenia-prevention
    Research shows that early intervention after a first episode of psychosis can improve a persons outcomes. […] Schizophrenia is not entirely preventable but various protective factors such as social support, mental health interventions, and avoiding substance use may help to reduce your risk of developing the condition. […] Earlier detection can slow the progression of schizophrenia and prevent psychosis episodes.
  • #6 Preventing Schizophrenia and Lowering Risks – Schizophrenia.com
    http://schizophrenia.com/prev1.htm
    Preventing Schizophrenia – Tactics and Risk Reduction Strategies […] Research conducted in the past decade indicates that schizophrenia is due to a genetic predisposition and environmental stressors early in a child’s development (during pregnancy and birth, and/or early childhood) which lead to subtle alterations in the brain that make a person susceptible to developing schizophrenia. […] In fact experts now say that schizophrenia (and all other mental illness) is caused by a combination of biological, psychological and social factors, and this understanding of mental illness is called the bio-psycho-social model. […] While the precise mechanisms that underlie the development of schizophrenia are just starting to be understood research does suggest many important actions that individuals and families can take (or avoid) to lower the risk of schizophrenia and other mental illnesses. […] Research now shows that in mental health the biology, psychology and social /emotional environment are closely interdependent – so factors in each of these areas are important to address.
  • #7 How to Prevent Schizophrenia | How to Avoid Schizophrenia | TX
    https://www.santecenter.com/rehab-blog/how-to-prevent-schizophrenia/
    Mental illness can be challenging to live with, and it can cause your life to become unmanageable. […] Knowing how to prevent schizophrenia, or at least manage the symptoms, is challenging but can be life-changing. […] When you’re trying to understand how to prevent schizophrenia, it’s essential to understand the risk factors. […] Schizophrenia has a genetic component, too, so you have a higher chance of having this condition if your parents, grandparents, siblings, or even extended family have seen the disorder appear in them. […] While there is no foolproof method for preventing schizophrenia, focusing on maintaining a healthy lifestyle and being aware of early symptoms can be beneficial. […] It is also vital to avoid substance abuse, as drugs and alcohol can trigger or exacerbate symptoms in vulnerable individuals. Early intervention and seeking professional help at the first sign of mental health difficulties can also be crucial in managing the condition and possibly preventing its full development.
  • #8 Is It Possible to Prevent Schizophrenia?
    https://www.webmd.com/schizophrenia/features/is-it-possible-to-prevent-schizophrenia
    Although there is no proven way to prevent schizophrenia, scientists are looking for ways to make it less likely. […] It’s possible that someone has genes linked to schizophrenia and then faces events that make them more likely to develop the disorder, says Julia Samton, MD, the director of Manhattan Neuropsychiatric PC in New York. […] Pregnancy complications. Infection, stress, and complications during pregnancy such as preeclampsia may raise the chance that your child will one day have schizophrenia. But that’s not certain. […] Depression or other major stressful events during pregnancy may also play a role. „A woman who experiences a death or other tragedy during pregnancy is also more likely to have a child at risk,” Samton says. […] Harmful childhood experiences. Brain injury, sexual abuse, and traumatic early experiences may raise the risk.
  • #9 Prenatal Folic Acid and Schizophrenia Prevention – Mass General Advances in Motion
    https://advances.massgeneral.org/neuro/video.aspx?id=1020
    Dr. Roffman discusses his recent work investigating folic acids neuroprotective effects that may guard against schizophrenia development […] They found that folic acid exposure in utero was associated with brain changes that appear to be protective against risk for schizophrenia.
  • #10 Early Detection and Prevention of Schizophrenic Psychosis—A Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8774083/
    Psychotic disorders often run a chronic course and are associated with a considerable emotional and social impact for patients and their relatives. Therefore, early recognition, combined with the possibility of preventive intervention, is urgently warranted since the duration of untreated psychosis (DUP) significantly determines the further course of the disease. […] In addition to established diagnostic tools, neurobiological factors in the development of schizophrenic psychoses are increasingly being investigated. It is shown that numerous molecular alterations already exist before the clinical onset of the disease. […] Therefore, the timely detection of schizophrenic psychosis is of paramount importance. In addition to the established diagnostic methods of symptom description, e.g., clinical interviews and psychometric questionnaires (test batteries), it is hoped that neurobiological disease markers will simplify the prediction and assessment of schizophrenic psychosis.
  • #11 Prevention: Before the break | Nature
    https://www.nature.com/articles/508S12a
    Paying attention to risk factors and warning signs could avert some cases of schizophrenia or at least better prepare people for what’s to come. […] A growing number of studies suggest that treating these early, muted signs can halve the number of people who later develop a break from reality. Researchers are also hunting for more concrete signs of risk in the brain, blood and saliva to better identify those at risk. Pre-emptive treatment could delay, or even avert, schizophrenia, and bring psychiatry into the realm of preventive medicine. […] Epidemiological studies have identified environmental risk factors that may contribute to errors in early brain development that are thought to underlie schizophrenia. For example, improving nutrition and avoiding infection during pregnancy may prevent some cases of the illness, and researchers are considering the possibility that getting the correct amount of vitamin D in early life could decrease the risk of schizophrenia.
  • #12 Is It Possible to Prevent Schizophrenia?
    https://www.webmd.com/schizophrenia/features/is-it-possible-to-prevent-schizophrenia
    „Children who were exposed to any trauma before age 16 were three times more likely to become psychotic,” Samton says. If the trauma was severe, children were 50 times more likely. […] Drug abuse. Early and long-term use of marijuana and other illicit drugs may raise the risk. […] Don’t use drugs. This is especially important for teens, because their brains are still developing. Remember, alcohol is a drug, so you should limit or avoid it. […] Avoid abusive or traumatic situations. If you’re in an abusive relationship or you’re going through trauma, get help. […] Keep strong social ties. Socializing helps you maintain self-esteem, lower stress, not feel lonely, and keep busy. […] Learn how to manage stress. Ongoing stress and anxiety are bad for your health. […] Take care of your body. Good nutrition and plenty of exercise are important.
  • #13 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Schizophrenia-Screening-Prevention-and-Management.aspx
    Schizophrenia is a rare mental health condition and the factors involved in its progression are unclear, making it difficult to screen for and prevent. […] Screening for schizophrenia is difficult because there are no reliable markers to indicate the subsequent development of the condition. […] There have been some public health campaigns aimed to educate the general public about schizophrenia, specific risk factors and early symptoms of the disease. […] Similarly to the screening for schizophrenia, prevention of the disease poses a challenge because we are not able to accurately determine which individuals are most likely to be affected. […] For this reason, the avoidance of drugs such as cannabis, cocaine and amphetamines is recommended in the prevention of schizophrenia. […] Social support is also very important for individuals to manage stressful life events and prevent triggers for the initiation of schizophrenia from occurring.
  • #14 How to Prevent Schizophrenia | How to Avoid Schizophrenia | TX
    https://www.santecenter.com/rehab-blog/how-to-prevent-schizophrenia/
    Studies suggest that one of the best ways to avoid developing schizophrenia includes avoiding social isolation. […] When isolated, whether by choice or accident, individuals can develop unhealthy mental habits and distorted understandings of the world around them. […] One of the primary risk factors for schizophrenia is the abuse of illicit drugs like methamphetamines and alcohol. […] Many people experience temporary psychosis while high, but in some cases, it doesn’t go away. […] If you’re struggling with an addiction, it’s definitely time to get some help. […] Fortunately, a dual diagnosis treatment program, like that offered at Sant Center for Healing, can treat both substance abuse and mental health issues. […] When a mental health condition like schizophrenia co-occurs with a substance use disorder, it requires specialized treatment called dual diagnosis treatment to address both issues simultaneously. […] It’s common for people to try to self-medicate when they’re struggling with mental illness, but this only makes things worse. […] If you’re ready to get the help that you deserve, call Sant Center for Healing today at 866.238.3154 or reach out online.
  • #15 Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention | Psychological Medicine | Cambridge Core
    https://www.cambridge.org/core/journals/psychological-medicine/article/prevention-of-psychosis-moving-on-from-the-atrisk-mental-state-to-universal-primary-prevention/D1BF4068B459A19D9EF2EBF67098B540
    The value of services for those with the At Risk Mental State for Psychosis (ARMS) continues to be disputed. […] We consider that the most productive approach for psychosis prevention is avoiding exposure to risk-increasing factors. The best-established risk factors for psychosis are obstetric events, childhood abuse, migration, city living, adverse life events and cannabis use. […] Therefore, as an initial step towards a strategy for universal primary prevention, we advocate public health campaigns to educate young people about the harms of regular use of high potency cannabis. […] We conclude that ARMS Clinics are never likely to make major inroads into preventing the majority of people who develop psychosis. An approach which could have a greater effect is to focus on avoiding the risk factors which increase the risk of the illness. […] Therefore, as an initial step towards universal primary prevention, we suggest major campaigns to educate young people about the harms of regular use of high potency cannabis.
  • #16 Early Detection and Prevention of Schizophrenic Psychosis—A Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8774083/
    The main instruments used to assess an ARMS are the Comprehensive Assessment of At-Risk Mental States (CAARMS) and the Structured Interview for Prodromal Symptoms (SIPS). […] The ultimate goal of early detection strategies is to prevent the transition into full-blown psychosis. Therefore, the effectiveness of cognitive behavioral therapy and antipsychotic medication is intensively studied. […] Even though favorable effects on positive and negative symptoms, as well as on cognitive functions were demonstrated, antipsychotic medication is currently not routinely recommended for the ARMS period. […] In conclusion, the reliable early detection of psychotic illness remains challenging to date. Although psychometric tests allowing predictions are available, their application in clinical routine is rather complex.
  • #17
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3190243/
    These clinical and psychosocial impairments justify defining the interventions in EPRS and LPRS as indicated prevention, pursuing the following three objectives: a) improvement in the current burden of prodromal symptoms; b) avoidance or perhaps delay in the development of psychosocial handicap; c) prevention of or at least delay or attenuation of psychosis. […] Five international intervention studies have attempted to find out whether or to what extent these three objectives can be reached. […] This differential prevention strategy is now pursued in all German early recognition centers and is also increasingly gaining support in other countries. […] A new prevention approach is driven by the idea of neuroprotection and studies indicating a progressive loss of gray matter volume before the onset of psychosis. […] In order to attain a major reduction in incidence, symptom-oriented risk assessment has to be enriched by neurobiological and psychosocial risk factors, and indicated prevention has to be further developed towards selective prevention.
  • #18 Schizophrenia Treatment & Management: Approach Considerations, Antipsychotic Pharmacotherapy, Other Pharmacotherapy
    https://emedicine.medscape.com/article/288259-treatment
    Many have wondered whether patients with schizophrenia would have a better prognosis if treatment could be started as early as possible. A study from Scandinavia found that early detection and intervention in first-episode psychosis led to higher recovery and employment rates at 10-year follow-up. […] The North American Prodrome Longitudinal Study is exploring whether the incorporation of biologic measures into prediction algorithms can provide more accurate identification of young people who are at greatest risk for developing a psychotic disorder. The goal of this study is to establish objective criteria that can be used to develop preventive approaches. […] One approach to this problem is to use psychological therapies rather than pharmacotherapy. A German study of young people at risk for schizophrenia showed that the use of a psychological intervention involving cognitive-behavioral therapy, group skills training, cognitive remediation and multifamily psychoeducation delayed the onset of psychosis for at least 2 years.
  • #19 Schizophrenia and Psychotic Disorder Research | Psychiatry | IU School of Medicine
    https://medicine.iu.edu/psychiatry/research/schizophrenia
    Located at Sydney Lois Eskenazi Health, the Prevention and Recovery Center for Early Psychosis (PARC) researchers focus on individuals in all stages of psychotic illnesses. […] This prevention and recovery program serves Indiana as a center of clinical care, research and educational excellence in the treatment of individuals in the early stages of schizophrenia. […] IU School of Medicine experts are working to significantly improve both the clinical condition and the long-term clinical outcome of patients who suffer from schizophrenia by intervening early in the course of the disease.
  • #20 Halting Schizophrenia Before It Starts : Shots – Health News : NPR
    https://www.npr.org/sections/health-shots/2014/10/20/356640026/halting-schizophrenia-before-it-starts
    McFarlane himself is careful about recommending antipsychotic medications. […] But in programs inspired by his model, the drugs appear to be widely prescribed, including in clients as young as 10 or 13. […] To see these programs in action, the best place to go is California, where over the past few years a handful of programs have sprung up based on McFarlane’s PIER model. […] McFarlane believes the benefits of these programs are borne out in the work done at his clinic and others based on his model. […] He and other proponents say schizophrenia’s early window may be too precious to miss. […] I thought we were going to have to take care of her for the rest of her life, says Kathy. […] Today Meghan is off all her medications. She’s animated, playing board games with her family, excited about being back in school.
  • #21 Indicated Prevention of Schizophrenia (25.07.2008)
    https://di.aerzteblatt.de/int/archive/article/61034
    The following three objectives have been specified: – improvement in the current burden of prodromal symptoms, – avoidance or perhaps delay in the developing psychosocial handicap, and above all – prevention of, or at least delay or attenuation in the threatened first psychotic disease. […] Five international intervention studies have attempted to find out whether or to what extent the three objectives for indicated prevention given above can be reached. […] This differential prevention strategy is now pursued in all German early recognition centers and is winning increasing numbers of adherents in other countries. […] On the basis of the available studies, the indicated prevention of schizophrenic disease must certainly be regarded as being at the stage of scientific testing. However, if the developments in this innovative area continue to be so rapid, it will be possible in the coming years to implement the evidence-based results in the practice of clinical care and, if at all possible, to provide every person with early warning signs seeking advice with individualized possible preventive strategies.
  • #22 Halting Schizophrenia Before It Starts : Shots – Health News : NPR
    https://www.npr.org/sections/health-shots/2014/10/20/356640026/halting-schizophrenia-before-it-starts
    The important thing is that Meghan knew something was wrong. […] At 19, Meghan hadn’t had a psychotic break. She still had insight. That made her eligible for a new type of program taking shape in California that aims to prevent schizophrenia before it officially begins. […] The program draws on research suggesting that schizophrenia unfolds much more slowly than might be obvious, even to families. […] McFarlane believes that psychosis can be prevented with a range of surprisingly low-tech interventions, almost all of which are designed to reduce stress in the family of the young person who is starting to show symptoms. […] Our theory, says McFarlane, was that if you could identify these young people early enough, you could alter some of those family patterns. […] McFarlane’s programs bring families in for twice-monthly multifamily group therapy sessions, where participants take a nuts-and-bolts approach to resolving disputes at home and softening their responses to what the young person is going through.
  • #23 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Schizophrenia-Screening-Prevention-and-Management.aspx
    There is some scientific evidence to support the use of early interventions to prevent the progression of an at-risk individual into suffering from schizophrenia. […] Cognitive behavior therapy (CBT) may help to reduce the risk of a subsequent episode and help patients prevent progression to schizophrenia.
  • #24 Treatment Challenges in Schizophrenia: A Multifaceted Approach to Relapse Prevention
    https://www.psychiatrictimes.com/view/treatment-challenges-schizophrenia-multifaceted-approach-relapse-prevention
    Switching to an injectable, long-acting antipsychotic may be suitable for certain patients and produce beneficial results in efficacy, tolerability, and relapse prevention. […] Patients and family members should be informed about the benefits and side effects of medications so that they can actively participate in the treatment effort. […] Adherence therapy and psychosocial skills training are also highly regarded. […] Dual-diagnosis programs are more likely to produce beneficial results for patients with schizophrenia than any 12-step program alone because they are designed to take into account the various symptomatic, cognitive, and social limitations of patients with schizophrenia. […] Accordingly, dual-diagnosis programs typically follow a „harm-reduction” model in which a decrease in drug use and its associated consequences, rather than total abstinence, is the goal of treatment.
  • #25 Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study | Nature Communications
    https://www.nature.com/articles/ncomms8934
    Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are essential for neural development and function. […] We have previously shown that a 12-week intervention with omega-3 PUFAs reduced the risk of progression to psychotic disorder in young people with subthreshold psychotic states for a 12-month period compared with placebo. […] Here we show that brief intervention with omega-3 PUFAs reduced both the risk of progression to psychotic disorder and psychiatric morbidity in general in this study. […] A recent meta-analysis in 2,502 at-risk individuals found that the cumulative rate of transition to psychosis increased over time, with 18%, 22%, 29% and 36% developing a psychotic disorder by 6 months, 1, 2 and 3 years, respectively. […] Reductions in the cell membrane levels of the omega-3 and omega-6 polyunsaturated fatty acid (PUFA) series have been observed in patients with schizophrenia.
  • #26 Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study | Nature Communications
    https://www.nature.com/articles/ncomms8934
    Since omega-3 PUFAs have no clinically relevant adverse effects and are considered generally beneficial to health, they are ideal for indicated prevention of psychosis. […] Here we report the longer-term efficacy of a 12-week intervention with fish oil capsules (providing omega-3 PUFAs, that is, 700mg of eicosapentaenoic acid and 480mg of docosahexaenoic acid daily) versus placebo capsules (matched in appearance and flavour with the active treatment) in individuals at ultrahigh risk for psychosis. […] We show that omega-3 PUFAs significantly reduced the risk of progression to psychotic disorder during the entire follow-up period. […] The cumulative conversion rate to psychosis at the longer-term follow-up was 9.8% (4/41) of subjects in the omega-3 PUFA group, and 40% (16/40) of subjects in the placebo group.
  • #27 Schizophrenia prevention opportunities are emerging | MDedge Psychiatry
    https://www.mdedge9-ma1.mdedge.com/psychiatry/article/97324/schizophrenia-other-psychotic-disorders/schizophrenia-prevention
    Schizophrenia prevention opportunities are emerging […] Reductions in stress, preventing drug use, and proactive cognitive support, as well as the development of targeted pharmacologic interventions are all currently being explored as ways to mitigate the disease. […] For primary prevention and secondary interventions, Dr. Keshavan said that, particularly in those in whom a risk for the illness already has been identified, reducing stress, enhancing cognitive abilities, and preventing drug use was key. In the near future, he anticipates that these kinds of behavioral interventions will be combined with cognitive-behavioral therapies, along with dopamine blockers, neuroprotective agents, and glutaminergic modulation, and perhaps even fish oil for its omega-3 fatty acids, as well as common anti-inflammatory agents such as aspirin.
  • #28 Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study | Nature Communications
    https://www.nature.com/articles/ncomms8934
    The majority of the individuals from the omega-3 group did not show severe functional impairment, were employed full-time, and no longer experienced attenuated psychotic symptoms at follow-up. […] This is the first study to show, to the best of our knowledge, that a 12-week intervention with omega-3 PUFAs prevented transition to full-threshold psychotic disorder and led to sustained symptomatic and functional improvements in young people with an at-risk mental state for 7 years (median). […] The overall psychiatric morbidity, indicated by meeting criteria for at least one DSM-IV Axis I disorder during the follow-up period, was also significantly lower in the omega-3 PUFA group. […] The findings imply that omega-3 PUFAs may have stopped processes associated with the manifestation of psychotic disorders. […] This first of its kind trial suggests that omega-3 PUFAs may offer a viable longer-term prevention strategy with minimal associated risk in young people at ultrahigh risk of psychosis.
  • #29 Schizophrenia – Wikipedia
    https://en.wikipedia.org/wiki/Schizophrenia
    Antipsychotics are prescribed following a first-episode psychosis, and following remission, a preventive maintenance use is continued to avoid relapse. However, it is recognized that some people do recover following a single episode and that long-term use of antipsychotics will not be needed but there is no way of identifying this group.
  • #30 Schizophrenia Relapse Prevention: Tips, Techniques, and More
    https://www.healthline.com/health/schizophrenia/schizophrenia-relapse-prevention
    Schizophrenia relapse prevention is multifaceted, and it starts with seeking professional support. […] Once symptoms start to improve, the goal is to keep them managed and to prevent future relapses. Overall, a schizophrenia relapse prevention plan incorporates every aspect of ongoing schizophrenia care. […] Relapses aren’t always possible to prevent, but you can take proactive steps to reduce how frequently you might experience symptom flare-ups. […] Keeping up with schizophrenia treatment is essential to preventing relapse. This means taking your medications as directed and monitoring for side effects. […] Eliminating these substances from your lifestyle can help prolong periods of remission, where your symptoms are gone or significantly improved. […] Schizophrenia relapse prevention is a part of overall schizophrenia management and treatment. […] By taking your medications as directed, keeping up with appointments, and sticking with psychotherapy, you’re already taking steps to prevent relapse. […] Other factors that can help include eliminating substance use, focusing on healthy lifestyle habits, and working closely with social supports.
  • #31 Prophylaxis in schizophrenia – GPnotebook
    https://gpnotebook.com/pages/gynaecology/long-term-treatment/prophylaxis-in-schizophrenia
    The prognosis for many patients is improved by the long term use of anti-psychotic medication either orally or in depot preparations (e.g. fluphenazine decanoate or flupenthixol i.m. every 3-4 weeks). […] Patients returning to an unsatisfactory family setting are in particular need of long term drug treatment. […] NICE in 2002 stated that atypical antipsychotic medication should be used in preference over typical antipsychotics but no longer make that assertion. […] When using antipsychotic medication then consider treatment with antipsychotic medication as an individual therapeutic trial. […] Inform service users about the high risk of relapse if medication is stopped in 1-2 years. […] Depot/long-acting injectable antipsychotics should be considered when service users would prefer this after an acute episode. […] Clozapine should be used if symptoms have not responded adequately despite sequential use of at least two different antipsychotics, one of which should be a non-clozapine second-generation antipsychotic.
  • #32 What Should You Do in Case of a Schizophrenia Relapse?
    https://www.webmd.com/schizophrenia/schizophrenia-psychosis-action-plan
    If you have a relapse despite your best efforts to prevent one, work with your doctor to figure out what caused it. That way, you can lower your chances of having another one. […] Take an honest, complete look back at what was going on in your life when you had the relapse, Duckworth says. Think about what you can learn from it. Then try to lower your odds of having another one with every decision you make. […] Some doctors use an FDA-approved medication called clozapine to treat people who have frequent relapses, Duckworth says. This antipsychotic drug may help if standard medications for schizophrenia dont control your symptoms.
  • #33 Strategies for relapse prevention among people with schizophrenia in KwaZulu-Natal Province, South Africa: Healthcare providers’ perspectives | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0316313
    The strategies for preventing relapse among schizophrenia comprise the quality of inpatient and outpatient care, especially primary health care, and the ability to ensure continuity of care after discharge. […] The period immediately after being discharged from the hospital is a critical time, as it represents a heightened risk for hospital readmission, suicide, and interruptions in the continuity of care for patients. […] In randomised controlled trials, the critical time intervention model (CTI) and assertive community treatment (ACT) have effectively prevented homelessness and re-hospitalization among patients with severe mental illness after discharge to the community settings. […] The quality of inpatient and outpatient care, as well as the effectiveness of the mental health system in providing well-coordinated care and support during a patients transition from hospital to ongoing community-based care, is crucial.
  • #34 Strategies for relapse prevention among people with schizophrenia in KwaZulu-Natal Province, South Africa: Healthcare providers’ perspectives | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0316313
    Good clinical practice in mental health care would consider at least one scheduled meeting with all parties concerned before discharge and family involvement as core elements. […] There are several advantages to discharge planning, including an increase in patient knowledge, a decline in clinical symptoms, and a reduction in hospital admission frequency. […] In SA, discharge planning and referral to aftercare support are severely lacking during psychiatric hospitalization, increasing the likelihood of relapse and recidivism and the risk of death. […] The strategies for preventing relapse among schizophrenia comprise the quality of inpatient and outpatient care, especially primary health care, and the ability to ensure continuity of care after discharge.
  • #35 Potential Increasing Trend in Schizophrenia Relapse Prevention in the Past 40 Years: A Bibliometric Analysis
    https://www.jpmph.org/journal/view.php?number=2384
    Objectives: Schizophrenia is an organic disease and a severe mental disorder with a relatively high risk of relapse. The rising rate of schizophrenia relapse has motivated researchers and academics to innovate and develop interventions aimed at relapse prevention. […] Family-centered relapse prevention is a key strategy in the management of schizophrenia. […] A variety of publications addressing relapse prevention in patients with schizophrenia have emerged, including a review focused on this topic. […] The impacts of relapse on families include heightened stress and emotional strain. […] Medication non-adherence is a major risk factor for patient relapse. […] The family dynamic also influences relapse, with contributing factors such as insufficient family support, high levels of expressed emotion within the family, inadequate knowledge about psychosis, and challenges in providing care for patients with schizophrenia.
  • #36 Best Practices in Schizophrenia Treatment (BeST) Center | NEOMED
    https://www.neomed.edu/bestcenter/
    Best Practices in Schizophrenia Treatment (BeST) Center […] With the right treatment and support, people with schizophrenia can and do recover. […] The BeST Center aims to transform the lives of individuals with schizophrenia by addressing the gap in access to effective treatment. We achieve this by offering tailored training and resources to both individuals and organizations dedicated to supporting those living with schizophrenia. […] Our six practices include FIRST Coordinated Specialty Care for First Episode Psychosis, Family Education and Support, Cognitive Behavioral Therapy for Psychosis, Integrated Primary and Mental Health Care, Pharmacotherapy for Schizophrenia, and Cognitive Remediation. […] Work is recovery: How supported employment helps people with psychosis. Getting a job can be a motivator for people who are being treated for mental illness like schizophrenia.
  • #37 Prevention: Before the break | Nature
    https://www.nature.com/articles/508S12a
    McGorry and others have taken the idea of early treatment further, proposing to intervene at the first suggestive signs of psychosis. […] Despite these diagnostic uncertainties, people deemed at risk for psychosis based on their behaviour carry marks of their vulnerability in their brains. […] So far, 11 randomized, controlled trials have found that treating people at risk results in fewer people developing psychosis within one year. […] Instead, studies in the past five years have emphasized safer treatments such as CBT, an approach that teaches people to recognize their own patterns of thinking and to reappraise situations. […] A more peculiar, and preliminary, finding points to beneficial effects of omega-3 fatty acid supplements in the form of fish oil. […] These findings point to the importance of nutrition and avoiding infection during pregnancy, which are already prominent messages for having a healthy baby in the developed world. These guidelines may already be reducing schizophrenia incidence in developed nations, and extending them to developing countries may bring further decreases.
  • #38 What Should You Do in Case of a Schizophrenia Relapse?
    https://www.webmd.com/schizophrenia/schizophrenia-psychosis-action-plan
    Schizophrenia relapses are common, and people get them for lots of reasons. But there are things you can do to lower your chances of having one. […] Use these tips as part of a relapse prevention plan that you create with your doctors and loved ones. If someone helps take care of you, they can put these steps into action for you. […] Work with your doctor to find out what your possible relapse warnings signs are. Once you know them, share the information with your family and anyone else involved in your care. Together, you can reach an agreement that youll call the doctor as soon as you notice any of these signs, Margolis says. […] Your wellness recovery action plan could include: […] Some people with schizophrenia get a psychiatric advance directive. This legal document spells out your treatment preferences in case youre unable to during a mental health crisis. It also allows a loved one to act on your behalf. Ask your doctor if that step is right for you.
  • #39 Strategies for relapse prevention among people with schizophrenia in KwaZulu-Natal Province, South Africa: Healthcare providers’ perspectives | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0316313
    Relapse is a significant challenge among people with schizophrenia and is broadly recognized by the aggravation of positive or negative symptoms, the need for re-hospitalization, more intensive case management, and/or changes in medication. […] The quality of inpatient care and proper transition to outpatient care are crucial in reducing the risk of relapse. […] This study explored the currently existing strategies for preventing relapse from the perspective of healthcare providers. […] Discharge planning and preparation are needed to ensure smooth transitions from hospital to outpatient care for relapse prevention. […] The healthcare system should ensure the availability of human resources for health at all levels of health facilities, and multidisciplinary teamwork will help a successful transition.
  • #40 Importance of Relapse Prevention in Schizophrenia
    https://www.ajmc.com/view/importance-of-relapse-prevention-in-schizophrenia
    When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. […] The risk of relapse is high, even after the very first episode of schizophrenia, and the risk of relapse is very much associated with whether or not one is taking medication. Its a very important message to get across to patients and families, that the reason were so strongly recommending continued medication is to prevent relapse. […] In terms of preventing relapse, its a very important point to consider whether or not we could identify early signs and be able to intervene before the relapse becomes full-blown and requires a significant change in treatment or hospitalization. […] We can also use technology to help us identify early signs of relapse. […] For example, nonadherence and medication taking is a big contributor to relapse.
  • #41 Importance of Relapse Prevention in Schizophrenia
    https://www.hcplive.com/view/importance-of-relapse-prevention-in-schizophrenia
    When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. […] The risk of relapse is high, even after the very first episode of schizophrenia, and the risk of relapse is very much associated with whether or not one is taking medication. Its a very important message to get across to patients and families, that the reason were so strongly recommending continued medication is to prevent relapse. Even though youre feeling fine now, we want to prevent a relapse down the road. […] In terms of preventing relapse, its a very important point to consider whether or not we could identify early signs and be able to intervene before the relapse becomes full-blown and requires a significant change in treatment or hospitalization. […] We can also use technology to help us identify early signs of relapse. […] For example, nonadherence and medication taking is a big contributor to relapse. Perhaps substance abuse might also be a big contributor to relapse.
  • #42 Beyond Mental Health: A Brain Health Approach to Schizophrenia Prevention and Care – European Brain Council (EBC)
    https://www.braincouncil.eu/event/beyond-mental-health-a-brain-health-approach-to-schizophrenia-prevention-and-care/
    Schizophrenia remains a major public health challenge, with significant personal, social and economic consequences. Traditional approaches to schizophrenia focus primarily on mental health interventions, yet emerging evidence underscores the need for a brain health perspectiveone that acknowledges the interplay between biological, psychological and social determinants. The event Beyond Mental Health: A Brain Health Approach to Schizophrenia Prevention and Care, building on the second and third phase of the Rethinking Schizophrenia Project, will explore how early intervention, innovative treatments and social policy reforms can reshape schizophrenia care across Europe. […] The aim of the roundtable is to discuss and present country-specific findings, illustrating barriers and best practices in implementing comprehensive care pathways in Poland. Experts will discuss youth-focused key policy recommendations, including early detection programs, access to innovative pharmacological and psychosocial treatments, integrated care models and digital health solutions. […] By adopting a biopsychosocial approach and integrating brain health into national policies, we can shift the paradigm in schizophrenia careensuring earlier interventions, better treatment outcomes and enhanced quality of life for young patients across Europe.
  • #43 Prevention and Early Interventions
    https://www.psychiatrictimes.com/view/prevention-and-early-interventions
    Comprehensive early psychosis treatment packages involving pharmacologic and psychosocial treatments as outlined above are more cost-effective than treatment as usual in improving long term recovery. […] Investing in early and comprehensive intervention can therefore improve our patients’ lives in the longer term as well as reduce overall costs of treatment. […] In summary, the evidence base of early interventions in schizophrenia is rapidly gaining acceptance in the field. However, as the field matures, it will be necessary to more extensively replicate the findings of the handful of early prevention studies.